Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
S100 calcium-binding protein B (S100B) is a calcium-binding protein.1 It is a homodimer, with each subunit containing two EF-hand calcium-binding domains. S100B is expressed primarily in astrocytes but also by neural progenitor cells, dendritic cells, some lymphocyte subpopulations, and maturing oligodendrocytes. SB100B has intracellular roles in calcium homeostasis, cell proliferation, energy metabolism, cytoskeletal regulation, and motility. It is also released extracellularly in response to various forms of brain injury and acts as a damage-associated molecular pattern (DAMP) through its interaction with receptor for advanced glycation end products (RAGE).1,2,3,4 Peripheral blood levels of SB100 are increased in patients with autism spectrum disorder, acute ischemic stroke, or neonatal brain injury.2,3,4 Cayman's S100B (C-Term) Rabbit Monoclonal Antibody (Clone RM304) can be used for immunohistochemistry (IHC) and Western blot (WB) applications.
WARNING This product is not for human or veterinary use.
1. Emerging role of S100B protein implication in Parkinson’s disease pathogenesis. Cell. Mol. Life Sci. 78(4), 1445-1453 (2021).
2. Peripheral blood S100B levels in autism spectrum disorder: A systematic review and meta-
3. Tau, S100B and NSE as blood biomarkers in acute cerebrovascular events. In Vivo 34(5), 2577-2586 (2020).
4. S100B as a biomarker of brain injury in premature neonates. A prospective case -